Full Name | Rand Chubin |
---|---|
Gender | Male |
Speciality | Occupational Therapist - Gerontology |
Location | 729 Park St, Antigo, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528433299 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 5724-26 (Wisconsin) | Secondary |
225XG0600X | Occupational Therapist - Gerontology | 572426 (Wisconsin) | Primary |
Provider Name | Phyt Rehab Of Wisconsin Inc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1366965931 PECOS PAC ID: 5395122196 Enrollment ID: O20220517001830 |
News Archive
Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eleven Collaborative Research Centres (CRCs) as of 1 January 2013. This was decided by the responsible Grants Committee during its fall session in Bonn.
India "has to actively and aggressively address the issue of family planning" in order to improve human development indicators, including health, education and living standards, UNFPA Executive Director Babatunde Osotimehin said Wednesday, Reuters reports.
Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising. Patients treated with CPX-351, a combination of the chemotherapeutic drugs cytarabine and daunorubicin, are showing better responses than patients treated with the standard drug formulation.
› Verified 7 days ago
Provider Name | Oasis Therapy Services Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1386381598 PECOS PAC ID: 8325427974 Enrollment ID: O20220706002370 |
News Archive
Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eleven Collaborative Research Centres (CRCs) as of 1 January 2013. This was decided by the responsible Grants Committee during its fall session in Bonn.
India "has to actively and aggressively address the issue of family planning" in order to improve human development indicators, including health, education and living standards, UNFPA Executive Director Babatunde Osotimehin said Wednesday, Reuters reports.
Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising. Patients treated with CPX-351, a combination of the chemotherapeutic drugs cytarabine and daunorubicin, are showing better responses than patients treated with the standard drug formulation.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Rand Chubin, W6593 E Midway Rd Apt 34, Appleton, WI 54915-4857 Ph: () - | Rand Chubin, 729 Park St, Antigo, WI 54409-2745 Ph: (715) 623-2356 |
News Archive
Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eleven Collaborative Research Centres (CRCs) as of 1 January 2013. This was decided by the responsible Grants Committee during its fall session in Bonn.
India "has to actively and aggressively address the issue of family planning" in order to improve human development indicators, including health, education and living standards, UNFPA Executive Director Babatunde Osotimehin said Wednesday, Reuters reports.
Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising. Patients treated with CPX-351, a combination of the chemotherapeutic drugs cytarabine and daunorubicin, are showing better responses than patients treated with the standard drug formulation.
› Verified 7 days ago
Elizabeth Ann Friske, OTR,CHT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 112 E 5th Ave, Antigo, WI 54409 Phone: 715-623-9449 Fax: 715-623-9425 | |
Katelyn Williams-parilek, MS, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 112 E 5th Ave, Antigo, WI 54409 Phone: 715-623-9449 | |
Mrs. Amy Michelle Zanayed, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 112 E 5th Ave, Antigo, WI 54409 Phone: 715-623-2331 | |
Mark G Buchman, MS, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 112 E 5th Ave, Antigo, WI 54409 Phone: 715-623-9449 Fax: 715-623-9425 | |
Mary R Brayton, MS, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 112 E 5th Ave, Antigo, WI 54409 Phone: 715-623-9469 | |
Michelle A Klingler, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 729 Park St, Antigo, WI 54409 Phone: 715-623-2356 |